About Us
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.
Arman C. Moshyedi, MD, PLLC (a division of Greenbrook TMS NeuroHealth Centers Services, LLC) is seeking a dedicated Board-Certified or Board-Eligible Psychiatrist to treat patients using Transcranial Magnetic Stimulation (TMS) therapy and help expand our Spravato® program in Ann Arbor.
Greenbrook operates more than 95 centers nationwide, specializing in advanced treatments for treatment-resistant depression, OCD, and other mental health disorders
As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients Our mission is to transform mental health care and improve lives through innovative solutions.
Depression affects more than 16 million Americans At Greenbrook, we’re changing the way it’s treated—and you can be part of that change.
Learn more:
GBSP25
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world.
NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain.
Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world.
If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Please visit NeuroStar.com/Safety for full safety and prescribing information.
